More than 3 million Americans have inherited bleeding disorders, and social determinants of health (SDOH) play a role in a number of ways, including cost for treatment, difficulty accessing specialists, educational barriers, and more.
A recent review examined the impact of social determinants of health (SDOH) on health outcomes for individuals with inherited bleeding disorders, such as hemophilia A, hemophilia B, von Willebrand disease, and others.
More than 3 million Americans have such disorders, and social determinants play a role in a number of ways, including cost for treatment, difficulty accessing specialists, educational barriers, and more.
The authors used PubMed to search for articles published in English between 2011 and 2021. Inclusion criteria included studies in which 1 of the following clinical outcomes were measured: bleeding frequency, chronic pain, mortality, quality of life, and/or cost of treatment, in a population diagnosed with an inherited bleeding disorder. In addition, results were restricted to free text articles.
The search resulted in 1466 original articles, and 13 articles were chosen for the analysis. Articles were categorized by categories of SDOH: health care system, economic stability, neighborhood/physical environment, community/social context, education, and food.
Several of the 13 articles overlapped multiple areas: 3 were categorized as economic stability, 1 was categorized as neighborhood and physical environment, 2 were categorized as education, 12 were categorized as community and social context, and 4 were categorized as health care systems. None fell into the food category.
The following themes were identified from the reports, which included case studies, literature reviews, and cross-sectional studies:
The analysis had several limitations, including the fact that the search was limited to free full-text English articles due to funding issues, and so there may be publication bias. The SDOH category of food was not analyzed in the results. Finally, most studies were observational designs.
The authors called for additional research, including studies that delve more deeply into specific areas of SDOH impact, such as food and neighborhoods.
Reference
Lopez K, Norris K, Hardy M, Valentino L. Defining the impact of social drivers on health outcomes for people with inherited bleeding disorders. J Clin Med. Published online July 30, 2022. doi:10.3390/jcm11154443
Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
May 15th 2024This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Read More
Health Equity, Accessibility Essential to Supporting Women Affected by Hemophilia
May 10th 2024Due to often being overlooked as only carriers of hemophilia, the review authors sought to highlight the needs of female caretakers for patients with the disorder and the possibility of women themselves being affected by it.
Read More
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More
Review: One-Shot Etranacogene Dezaparvovec Represents Game-Changing Gene Therapy for Hemophilia B
May 3rd 2024More than 20 years of gene therapy clinical research have led to etranacogene dezaparvovec’s use in hemophilia B, according to authors of a recent review—and it takes its place in a line of current and potentially many future genomic medicines for a range of diseases.
Read More
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More